{"prompt": "['2017N330177_04', 'CONFIDENTIAL', '205678', 'Thompson JA, Motzer R, Molina AM, Choueiri TK, Heath EI, Kollmannsberger CK, et', 'al. Phase I studies of anti-ENPP3 antibody drug conjugates (ADCs) in advanced', 'refractory renal cell carcinomas (RRCC). J. Clin. Oncol. 2015; 33:2503.', 'Usmani SZ, Weiss BM, Plesner T, Bahlis NJ, Belch A, Lonial S, et al. Clinical efficacy', 'of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory', 'multiple myeloma. Blood. 2016;128(1):37-44.', 'Varfolomeev E, Kischkel F, Martin F, Seshasayee D, Wang H, Lawrence D, et al.', 'APRIL-deficient mice have normal immune system development. Mol Cell Biol.', '2004;24(3):997-1006.', 'Weisel K, San Miguel JF, Song KW, Delforge M, Karlin L, Goldschmidt H, et al. MM-', '003 phase 3 study of pomalidomide in combination with low-dose dexamethasone (Pom', '+ LoDex) VS high-dose dexamethasone (Hi-Dex) in relapsed/refractory multiple myeloma', '(RRMM): Pom + LoDex is beneficial for elderly patients (>65 years of age). Blood.', '2013; 122:3198.', '104']['2017N330177_04', 'CONFIDENTIAL', '205678', '12.', 'APPENDICES', '12.1.', 'Appendix 1: Abbreviations and Trademarks', 'ADA', 'Anti-drug antibodies', 'ADC', 'Antibody drug conjugate', 'ADCC', 'Antibody dependent cellular cytotoxicity', 'ADL', 'Activities of daily living', 'AE', 'Adverse Event', 'AESI', 'Adverse events of special interest', 'ALP', 'Alkaline phosphatase', 'ALT', 'Alanine aminotransferase', 'ANC', 'Absolute neutrophil count', 'Anti-CD38', 'Anti-CD38 antibody', 'APRIL', 'A proliferation-inducing ligand', 'AST', 'Aspartate aminotransferase', 'AUC', 'Area under the curve', 'AV', 'Atrioventricular', 'BAFF', 'B-cell-activating factor belonging to the TNF family', 'BCMA', 'B-cell maturation antigen', 'BCVA', 'Best corrected visual acuity', 'BIB', 'Bioanalysis Immunogenicity and Biomarkers', 'BiTe', 'Bispecific antibodies', 'BLRM', 'Bayesian Logistic Regression Model', 'BM', 'Bone marrow', 'BNP', 'B-type natriuretic peptide', 'BP', 'Blood Pressure', 'BUN', 'Blood urea nitrogen', 'C1D1', 'Cycle 1 Day 1', 'CAR-T', 'Chimeric antigen receptor T-Cell', 'CBR', 'Clinical Benefit Rate', 'cfDNA', 'Circulating cell-free deoxyribonucleic acid', 'CFR', 'Code of Federal Regulations', 'CI', 'Confidence interval', 'CIOMS', 'Council of International Organizations of Medical Sciences', 'CK', 'Creatine kinase', 'CL', 'Clearance', 'Cmax', 'Maximum observed concentration', 'CO2', 'Carbon dioxide', 'CONSORT', 'Consolidated Standards of Reporting Trials', 'COPD', 'Chronic Obstructive Pulmonary Disease', 'CPK', 'Creatine phosphokinase', 'CR', 'Complete Response', 'CRF', 'Case Report Form', 'CRP', 'C-reactive protein', 'CSR', 'Clinical study report', '105']['2017N330177_04', 'CONFIDENTIAL', '205678', 'CT', 'Computed tomography', 'CTCAE', 'Common Terminology Criteria for Adverse Events', 'CV', 'Coefficient of variation', 'DAMPs', 'Danger-associated molecular patterns', 'DCs', 'Dendritic cells', 'DICOM', 'Digital Imaging and Communications in Medicine', 'DILI', 'Drug-induced liver injury', 'DLT', 'Dose limiting toxicities', 'DNA', 'Deoxyribonucleic acid', 'DOR', 'Duration of Response', 'EC', 'Ethics committee', 'ECG', 'Electrocardiogram', 'ECHO', 'Echocardiogram', 'ECOG', 'Eastern Cooperative Oncology Group', 'eCRF', 'Electronic case report form', 'eGFR', 'Estimated glomerular filtration rate', 'EORTC', 'European Organization for Research and Treatment of Cancer', 'EOT', 'Endo of treatment', 'EQ-5D-5L', 'EuroQOL Group EQ-5D 5 Level', 'FISH', 'Fluorescence in situ hybridization', 'FLC', 'Free light chain', 'FSFV', 'First subject first visit', 'FSH', 'Follicle stimulating hormone', 'FTIH', 'First Time in Human Trial', 'GCP', 'Good Clinical Practice', 'GFR', 'Glomerular filtration rate', 'GGT', 'Gamma glutamyl transferase', 'GSK', 'GlaxoSmithKline', 'HBV', 'Hepatitis B', 'HCV', 'Hepatitis C virus', 'HIPAA', 'Health Insurance Portability and Accountability Act', 'HIV', 'Human Immunodeficiency Virus', 'HLA', 'Human leukocyte antigen', 'HR', 'Hazard ratio', 'HRT', 'Hormone replacement therapy', 'HSCT', 'Hematopoietic stem cell transplantation', 'IB', 'Investigator Brochure', 'ICD', 'Immunogenic cell death', 'ICH', 'International Conference on Harmonization', 'IDMC', 'Independent Data Monitoring Committee', 'IEC', 'Institutional Ethics Committee', 'IgA', 'Immunoglobulin A', 'IgG', 'Immunoglobulin G', 'IgM', 'Immunoglobulin M', 'IHC', 'Immunohistochemistry', 'IMiD', 'Immunomodulatory drugs', '106']\n\n###\n\n", "completion": "END"}